Russian drug to treat Covid to be delivered to hospitals in June

Avifavir is Russia’s first COVID-19 drug and has shown high efficacy in treating patients with coronavirus during clinical trials. Avifavir has received a registration certificate from the Ministry of Health of the Russian Federation. Thus, Avifavir has become the first Favipiravir-based drug in the world approved for the treatment of COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TXP4pm
via IFTTT